Do impaired memory, cognitive dysfunction and distress play a role in methotrexate-related neutropenia in rheumatoid arthritis patients? A comparative study

Rheumatology International

Volumn 33, Issue 10, 2013, Pages 2631-2635

  Pamuk, Omer Nuri ^a,e   Kisacik, Bunyamin ^b   Pamuk, Gulsum Emel ^a   Onat, Ahmet Mesut ^b   Sayarlioglu, Mehmet ^c   Donmez, Salim ^a   Pehlivan, Yavuz ^b   Keystone, Edward C ^d  

^a TRAKYA UNIVERSITY   (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

^c KSU Medical School   (Turkey)

^d UNIVERSITY OF TORONTO   (Canada)

^e NONE   (Turkey)

Author keywords

Anxiety; Depression; Methotrexate; Mini mental state examination; Neutropenia; Rheumatoid arthritis

Indexed keywords

CREATININE; METHOTREXATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMENTIA; DISTRESS SYNDROME; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LOWEST INCOME GROUP; MALE; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; NEUTROPENIA; PATIENT EDUCATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MEMORY DISORDERS; METHOTREXATE; MIDDLE AGED; NEUTROPENIA; STRESS, PSYCHOLOGICAL;

EID: 84885378395     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2792-2     Document Type: Article

References (21)

1. Sany J, Anaya JM, Lussiez V, Couret M, Combe B, Daures JP (1991) Treatment of rheumatoid arthritis with methotrexate: a prospective open longterm study of 191 cases. J Rheumatol 18:1323-1327
2. Kremer JM, Phelps CT (1992) Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months. Arthritis Rheum 35:138-145
3. Alarcón GS, Tracy IC, Strand GM, Singh K, Macaluso M (1995) Survival and drug discontinuation analyses in a large cohort of methotrexate treated rheumatoid arthritis patients. Ann Rheum Dis 54:708-712
4. Yazici Y (2010) Long-term safety of methotrexate in the treatment of rheumatoid arthritis. Clin Exp Rheumatol 28:S65-S67
5. Salliot C, van der Heijde D (2009) Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis 68:1100-1104
6. Suarez-Almazor ME, Belseck E, Shea B, Wells G, Tugwell P (2000) Methotrexate for rheumatoid arthritis. Review. Cochrane Database Syst Rev 2:CD000957
7. Alarcón GS, Tracy IC, Blackburn WD Jr (1989) Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum 32(6):671-676
8. Verstappen SM, Bakker MF, Heurkens AH et al (2010) Utrecht rheumatoid arthritis cohort study group. Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy: the CAMERA study. Ann Rheum Dis 69:1044-1048
9. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
10. Folstein MF, Folstein S, Mc Hugh PR (1975) 'Mini Mental State' a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 12:189-198
11. Molloy DW, Alemayehu E, Roberts R (1991) Reliability of a standardized mini-mental state examination compared with the traditional mini-mental state examination. Am J Psychiatry 148:102-105
12. Güngen C, Ertan T, Eker E, Yaşar R, Engin F (2002) Reliability and validity of the standardized mini mental state examination in the diagnosis of mild dementia in Turkish population. Turk Psikiyatri Derg 13:273-281 (Article in Turkish)
13. Friedman TW, Yelland GW, Robinson SR (2011) Subtle cognitive impairment in elders with mini-mental state examination scores within the 'normal' range. Int J Geriatr Psychiatry 27:463-471
14. Aydemir O (1997) Hastane anksiyete ve depresyon ölçeǧi Türkçe formunun geçerlilik ve güvenilirlik çalIşmasI. Türk Psikiyatri Dergisi 8:280-287 (Article in Turkish)
15. Al-Hasani H, Roussou E (2011) Methotrexate for rheumatoid arthritis patients who are on hemodialysis. Rheumatol Int 31:1545-1547
16. Isik A, Koca SS, Ozturk A, Mermi O (2007) Anxiety and depression in patients with rheumatoid arthritis. Clin Rheumatol 26:872-878
17. VanDyke MM, Parker JC, Smarr KL et al (2004) Anxiety in rheumatoid arthritis. Arthritis Rheum 51:408-412
18. Fisher MC, Cronstein BN (2009) Metaanalysis of methylene tetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity. J Rheumatol 36:539-545
19. Ranganathan P, Culverhouse R, Marsh S et al (2008) Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis. J Rheumatol 35:572-579
20. Efrati E, Elkin H, Nahum S, Krivoy N (2013) Population distribution of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C risk alleles for methotrexate toxicity in Israel. Rheumatol Int 33:1001-1004
21. Malysheva OA, Wahle M, Wagner U, Pierer M, Arnold S, Häntzschel H, Baerwald CG (2008) Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs. J Rheumatol 35:979-985